Association between tacrolimus pharmacokinetics and cytochrome P450 3A5 and multidrug resistance protein 1 exon 21 polymorphisms

M Soda, M Fujitani, R Michiuchi, A Shibayama… - Transplantation …, 2017 - Elsevier
Background Individual differences in the pharmacokinetics (PK) of tacrolimus (TAC), an
immunosuppressive drug, are reportedly associated with single-nucleotide polymorphisms …

Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms.

M Soda, M Fujitani, R Michiuchi… - Transplantation …, 2017 - europepmc.org
Background Individual differences in the pharmacokinetics (PK) of tacrolimus (TAC), an
immunosuppressive drug, are reportedly associated with single-nucleotide polymorphisms …

Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms

M Soda, M Fujitani, R Michiuchi… - Transplantation …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Individual differences in the pharmacokinetics (PK) of tacrolimus (TAC), an
immunosuppressive drug, are reportedly associated with single-nucleotide polymorphisms …

[引用][C] Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms

M Soda, M Fujitani, R Michiuchi, A Shibayama… - Transplantation …, 2017 - cir.nii.ac.jp
Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug
Resistance Protein 1 Exon 21 Polymorphisms | CiNii Research CiNii 国立情報学研究所 学術 …